share_log

昭衍新药(06127.HK):无锡金易赋新生物医药创业投资合伙企业完成备案手续

Joinn Laboratories (06127.HK): Wuxi Jinyifu Xin Biomedical Venture Capital Partnership Enterprise Completes Record Filing Procedures.

Gelonghui Finance ·  Jul 24 06:44

Joinn Laboratories (06127.HK) announced on July 24th that on July 23rd, 2024, the company received a notice that Wuxi Jinyi Fu Xinxin Biological Pharmaceutical Entrepreneurship Investment Partnership Enterprise (Limited Partnership) had completed the filing procedures with the Association of Securities Investment Fund Industry in accordance with the requirements of the Securities Investment Fund Law, the Interim Measures for the Supervision and Administration of Private Investment Funds, and other laws and regulations, and obtained the Private Investment Fund Filing Certificate.

Fund Name: Wuxi Jinyi Fu Xinxin Biological Pharmaceutical Entrepreneurship Investment Partnership Enterprise (Limited Partnership); Manager Name: Wuxi Guolian Industrial Investment Private Equity Fund Management Co., Ltd.; Trustee Name: CM Bank Co., Ltd.; Filing Code: SALS15; Filing Date: July 23, 2024.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment